SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001551986-20-000131
Filing Date
2020-05-04
Accepted
2020-05-04 19:40:41
Documents
2
Period of Report
2020-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158863562292561.html 4  
1 FORM 4 wf-form4_158863562292561.xml 4 4765
2 POA - NDARIVSH 2020 ex-24.htm EX-24 3341
  Complete submission text file 0001551986-20-000131.txt   9724
Mailing Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615
Business Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615 919-275-1933
INNOVATE BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0001551986 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INNOVATE BIOPHARMACEUTICALS, INC. 8480 HONEYCUTT ROAD, SUITE 120 RALEIGH NC 27615
Business Address
Darvish Nissim (Reporting) CIK: 0001793602 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37797 | Film No.: 20846462